These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Passive protection of mice against lethal Francisella tularensis (live tularemia vaccine strain) infection by the sera of human recipients of the live tularemia vaccine. Drabick JJ; Narayanan RB; Williams JC; Leduc JW; Nacy CA Am J Med Sci; 1994 Aug; 308(2):83-7. PubMed ID: 8042659 [TBL] [Abstract][Full Text] [Related]
4. Oral immunization of mice with the live vaccine strain (LVS) of Francisella tularensis protects mice against respiratory challenge with virulent type A F. tularensis. KuoLee R; Harris G; Conlan JW; Chen W Vaccine; 2007 May; 25(19):3781-91. PubMed ID: 17346863 [TBL] [Abstract][Full Text] [Related]
6. Identification of Francisella tularensis outer membrane protein A (FopA) as a protective antigen for tularemia. Hickey AJ; Hazlett KR; Kirimanjeswara GS; Metzger DW Vaccine; 2011 Sep; 29(40):6941-7. PubMed ID: 21803089 [TBL] [Abstract][Full Text] [Related]
7. Efficacy of the live attenuated Francisella tularensis vaccine (LVS) in a murine model of disease. Green M; Choules G; Rogers D; Titball RW Vaccine; 2005 Apr; 23(20):2680-6. PubMed ID: 15780452 [TBL] [Abstract][Full Text] [Related]
9. Susceptibility of immunodeficient mice to aerosol and systemic infection with virulent strains of Francisella tularensis. Chen W; KuoLee R; Shen H; Conlan JW Microb Pathog; 2004 Jun; 36(6):311-8. PubMed ID: 15120157 [TBL] [Abstract][Full Text] [Related]
10. Correlates of protection following vaccination of mice with gene deletion mutants of Francisella tularensis subspecies tularensis strain, SCHU S4 that elicit varying degrees of immunity to systemic and respiratory challenge with wild-type bacteria. Ryden P; Twine S; Shen H; Harris G; Chen W; Sjostedt A; Conlan W Mol Immunol; 2013 May; 54(1):58-67. PubMed ID: 23201853 [TBL] [Abstract][Full Text] [Related]
11. A ΔclpB mutant of Francisella tularensis subspecies holarctica strain, FSC200, is a more effective live vaccine than F. tularensis LVS in a mouse respiratory challenge model of tularemia. Golovliov I; Twine SM; Shen H; Sjostedt A; Conlan W PLoS One; 2013; 8(11):e78671. PubMed ID: 24236032 [TBL] [Abstract][Full Text] [Related]
12. Differential ability of novel attenuated targeted deletion mutants of Francisella tularensis subspecies tularensis strain SCHU S4 to protect mice against aerosol challenge with virulent bacteria: effects of host background and route of immunization. Conlan JW; Shen H; Golovliov I; Zingmark C; Oyston PC; Chen W; House RV; Sjöstedt A Vaccine; 2010 Feb; 28(7):1824-31. PubMed ID: 20018266 [TBL] [Abstract][Full Text] [Related]
13. Tularemia in BALB/c and C57BL/6 mice vaccinated with Francisella tularensis LVS and challenged intradermally, or by aerosol with virulent isolates of the pathogen: protection varies depending on pathogen virulence, route of exposure, and host genetic background. Chen W; Shen H; Webb A; KuoLee R; Conlan JW Vaccine; 2003 Sep; 21(25-26):3690-700. PubMed ID: 12922099 [TBL] [Abstract][Full Text] [Related]
14. Inactivated Francisella tularensis live vaccine strain protects against respiratory tularemia by intranasal vaccination in an immunoglobulin A-dependent fashion. Baron SD; Singh R; Metzger DW Infect Immun; 2007 May; 75(5):2152-62. PubMed ID: 17296747 [TBL] [Abstract][Full Text] [Related]
15. Virulence comparison in mice of distinct isolates of type A Francisella tularensis. Twine SM; Shen H; Kelly JF; Chen W; Sjöstedt A; Conlan JW Microb Pathog; 2006 Mar; 40(3):133-8. PubMed ID: 16448801 [TBL] [Abstract][Full Text] [Related]
16. Novel catanionic surfactant vesicle vaccines protect against Francisella tularensis LVS and confer significant partial protection against F. tularensis Schu S4 strain. Richard K; Mann BJ; Stocker L; Barry EM; Qin A; Cole LE; Hurley MT; Ernst RK; Michalek SM; Stein DC; Deshong P; Vogel SN Clin Vaccine Immunol; 2014 Feb; 21(2):212-26. PubMed ID: 24351755 [TBL] [Abstract][Full Text] [Related]
17. Identification of a live attenuated vaccine candidate for tularemia prophylaxis. Mahawar M; Rabadi SM; Banik S; Catlett SV; Metzger DW; Malik M; Bakshi CS PLoS One; 2013; 8(4):e61539. PubMed ID: 23613871 [TBL] [Abstract][Full Text] [Related]
18. Vaccination with a defined Francisella tularensis subsp. novicida pathogenicity island mutant (DeltaiglB) induces protective immunity against homotypic and heterotypic challenge. Cong Y; Yu JJ; Guentzel MN; Berton MT; Seshu J; Klose KE; Arulanandam BP Vaccine; 2009 Sep; 27(41):5554-61. PubMed ID: 19651173 [TBL] [Abstract][Full Text] [Related]
19. Attenuation and protective efficacy of an O-antigen-deficient mutant of Francisella tularensis LVS. Li J; Ryder C; Mandal M; Ahmed F; Azadi P; Snyder DS; Pechous RD; Zahrt T; Inzana TJ Microbiology (Reading); 2007 Sep; 153(Pt 9):3141-3153. PubMed ID: 17768257 [TBL] [Abstract][Full Text] [Related]
20. Mouse model of oral infection with virulent type A Francisella tularensis. KuoLee R; Zhao X; Austin J; Harris G; Conlan JW; Chen W Infect Immun; 2007 Apr; 75(4):1651-60. PubMed ID: 17242058 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]